Cargando…

Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma

BACKGROUND/AIMS: We aimed to evaluate the efficacy and safety of an immunosuppressive regimen without steroids after liver transplantation (LT) for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). METHODS: Sixty-six HCC patients who underwent an immunosuppressive regimen without stero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Qiang, Xu, Xiao, Wang, Chao, Zhuang, Runzhou, Zhuang, Li, Zhou, Lin, Xie, Haiyang, Wu, Jian, Zhang, Min, Shen, Yan, Wang, Weilin, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933422/ https://www.ncbi.nlm.nih.gov/pubmed/27074818 http://dx.doi.org/10.5009/gnl15017

Ejemplares similares

Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
por: Liu, Yuan-Yuan, et al.
Publicado: (2015)

Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
por: Xing, Tonghai, et al.
Publicado: (2013)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
Publicado: (2019)

Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry
por: Ling, Qi, et al.
Publicado: (2017)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
Publicado: (2019)

Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study
por: Ling, Qi, et al.
Publicado: (2015)

Towards Steroid-Free Immunosuppression after Liver Transplantation
por: Zaydfudim, Victor M., et al.
Publicado: (2016)

The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
por: Chen, Jun, et al.
Publicado: (2014)

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
por: Wang, Jianguo, et al.
Publicado: (2013)

A case report of de novo hepatocellular carcinoma after living donor liver transplantation
por: Yu, Songfeng, et al.
Publicado: (2013)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhuang, Runzhou, et al.
Publicado: (2017)

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma
por: Zhang, Xuanyu, et al.
Publicado: (2019)

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation
por: Xia, Weiliang, et al.
Publicado: (2015)

Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials
por: Gu, Jinyang, et al.
Publicado: (2014)

Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation
por: Wang, Wenchao, et al.
Publicado: (2021)

Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure
por: Ling, Qi, et al.
Publicado: (2012)

Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
por: Yu, Xiaobo, et al.
Publicado: (2011)

Comparative Safety and Efficacy of Immunosuppressive Regimens Post-kidney Transplant: A Systematic Review
por: Qayyum, Shahid, et al.
Publicado: (2023)

Intestinal Microbial Variation May Predict Early Acute Rejection after Liver Transplantation in Rats
por: Ren, Zhigang, et al.
Publicado: (2014)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
por: Chen, Jun, et al.
Publicado: (2022)

Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Tang, Yunhua, et al.
Publicado: (2021)

Does steroid-free immunosuppression improve the outcome in kidney transplant recipients compared to conventional protocols?
por: Aref, Ahmed, et al.
Publicado: (2021)

Patient involvement in selection of immunosuppressive regimen following transplantation
por: Popoola, Joyce, et al.
Publicado: (2014)

Transplantation: Polyomavirus Nephropathy and the Risk of Specific Immunosuppression Regimens
por: Wu, Christine, et al.
Publicado: (2006)

MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation
por: Wu, Liming, et al.
Publicado: (2018)

A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation
por: Yang, Zhentao, et al.
Publicado: (2023)

Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma
por: Yan, Yingcai, et al.
Publicado: (2016)

BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis
por: Wang, Weilin, et al.
Publicado: (2015)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
por: Satapathy, Sanjaya K., et al.
Publicado: (2017)

Polyploidy Spectrum Correlates with Immunophenotype and Shapes Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Zhang, Liang, et al.
Publicado: (2022)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

BAG3 and HIF-1α Coexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation
por: Xiao, Heng, et al.
Publicado: (2014)

Liver transplantation: immunosuppression and oncology
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2014)

Update on Immunosuppression in Liver Transplantation
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sitsgjplgr04rdmiorofp7hm68